• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Abbott study finds disparities in critical limb ischemia management

Abbott study finds disparities in critical limb ischemia management

October 7, 2021 By Sean Whooley

AbbottAbbott (NYSE:ABT) announced that it presented impactful findings surrounding disparities in critical limb ischemia (CLI) management.

Presenting at VIVA’s late-breaking clinical trials, Abbott’s shared that it found that a majority of 7,904 Medicare beneficiaries who underwent an amputation had no attempt at a vascular procedure in the year prior to the amputation.

The study evaluated Medicare claims data from 2016 to 2019 to identify fee-for-service beneficiaries with a diagnosis of CLI patients who underwent a major lower-limb amputation, according to a news release. Among those observed, 63.4% received low-intensity vascular care, 5.5% received medium-intensity vascular care and 31.1% received high-intensity vascular care.

Abbott Park, Illinois-based Abbott said low intensity of vascular care received in the year leading up to the amputation was also associated with a greater risk of death and readmission.

Dr. Eric Secemsky of the Smith Center for Outcomes Research in Cardiology, who collaborated with Abbott on the study, said the burden of CLI leaves an impact on patients well after life-altering events, adding that the study identified ways to improve care before and after amputation.

“An objective multidisciplinary vascular assessment is critical prior to amputation as high and medium intensity of care can lower a patient’s risk of death by 23.8% and 21.8%, respectively,” Dr. Nick West, CMO and divisional VP of global medical affairs at Abbott’s vascular business, said in the news release. “However, disparities continue to exist in contemporary vascular practice, and our data reveal that being male, low-income, or receiving care at a safety-net hospital were all strongly associated with receiving lower-intensity vascular care prior to amputation.”

Filed Under: Cardiovascular, Clinical Trials, Featured, Vascular Tagged With: Abbott

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy